Dclk1 distinguishes between tumor and normal stem cells in the intestine

Nature Genetics

Volumn 45, Issue 1, 2013, Pages 98-103

  Nakanishi, Yuki ^a   Seno, Hiroshi ^a   Fukuoka, Ayumi ^b   Ueo, Taro ^a   Yamaga, Yuichi ^a   Maruno, Takahisa ^a   Nakanishi, Naoko ^a   Kanda, Keitaro ^a   Komekado, Hideyuki ^a   Kawada, Mayumi ^a   Isomura, Akihiro ^b   Kawada, Kenji ^a   Sakai, Yoshiharu ^a   Yanagita, Motoko ^a   Kageyama, Ryoichiro ^b   Kawaguchi, Yoshiya ^c   Taketo, Makoto M ^a   Yonehara, Shin ^b   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLECORTIN; DOUBLECORTIN LIKE KINASE 1; PHOSPHOTRANSFERASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; COLORECTAL CANCER; DISEASE MARKER; GENE DELETION; INTESTINE; INTESTINE POLYP; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN TARGETING; STEM CELL;

MUS;

EID: 85027944761     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.24813     Document Type: Article

References (32)

1. Dalerba, P. et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 104, 10158-10163 (2007).
2. O'Brien, C.A., Pollett, A., Gallinger, S. & Dick, J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110 (2007).
3. Zhu, L. et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457, 603-607 (2009).
4. Todaro, M., Francipane, M.G., Medema, J.P. & Stassi, G. Colon cancer stem cells: Promise of targeted therapy. Gastroenterology 138, 2151-2162 (2010).
5. Giannakis, M. et al. Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches. J. Biol. Chem. 281, 11292-11300 (2006).
6. May, R. et al. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 26, 630-637 (2008).
7. Gerbe, F., Brulin, B., Makrini, L., Legraverend, C. & Jay, P. DCAMKL-1 expression identifies Tuft cells rather than stem cells in the adult mouse intestinal epithelium. Gastroenterology 137, 2179-2180 (2009).
8. Saqui-Salces, M. et al. Gastric tuft cells express DCLK1 and are expanded in hyperplasia. Histochem. Cell Biol. 136, 191-204 (2011).
9. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007 (2007).
10. Sangiorgi, E. & Capecchi, M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 40, 915-920 (2008).
11. Bonnet, D. & Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737 (1997).
12. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. & Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988 (2003).
13. Singh, S.K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828 (2003).
14. Li, C. et al. Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030-1037 (2007).
15. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115 (2007).
16. Cocciadiferro, L. et al. Profiling cancer stem cells in androgen-responsive and refractory human prostate tumor cell lines. Ann. NY Acad. Sci. 1155, 257-262 (2009).
17. Clevers, H. The cancer stem cell: Premises, promises and challenges. Nat. Med. 17, 313-319 (2011).
18. Davies, E.J., Marsh, V. & Clarke, A.R. Origin and maintenance of the intestinal cancer stem cell. Mol. Carcinog. 50, 254-263 (2011).
19. May, R. et al. Doublecortin and CaM kinase-like-1 and leucine-rich-repeatYcontaining G-proteinYcoupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells 27, 2571-2579 (2009).
20. Gerbe, F. et al. Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J. Cell Biol. 192, 767-780 (2011).
21. Koizumi, H., Tanaka, T. & Gleeson, J.G. Doublecortin-like kinase functions with doublecortin to mediate fiber tract decussation and neuronal migration. Neuron 49, 55-66 (2006).
22. Sauer, B. & Henderson, N. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol. 2, 441-449 (1990).
23. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999).
24. Vermeulen, L. et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl. Acad. Sci. USA 105, 13427-13432 (2008).
25. Verissimo, C.S. et al. Silencing of the microtubule-associated proteins doublecortin-like and doublecortin-like kinase-long induces apoptosis in neuroblastoma cells. Endocr. Relat. Cancer 17, 399-414 (2010).
26. Harada, N. et al. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene. EMBO J. 18, 5931-5942 (1999).
27. Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611 (2009).
28. Visvader, J.E. & Lindeman, G.J. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768 (2008).
29. Graham, S.M. et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99, 319-325 (2002).
30. Saito, M. et al. Diphtheria toxin receptorYmediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 19, 746-750 (2001).
31. Buch, T. et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419-426 (2005).
32. Merlos-Suárez, A. et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511-524 (2011).